Defining cardiac fibrosis complexity and regulation towards therapeutic development
Abstract Cardiac fibrosis is insidious, accelerating cardiovascular diseases, heart failure, and death. With a notable lack of effective therapies, advances in both understanding and targeted treatment of fibrosis are urgently needed. Remodelling of the extracellular matrix alters the biomechanical...
Main Authors: | Bethany Claridge, Auriane Drack, Alexander R. Pinto, David W. Greening |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Clinical and Translational Discovery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctd2.163 |
Similar Items
-
Cardiomyocyte intercellular signalling increases oxidative stress and reprograms the global‐ and phospho‐proteome of cardiac fibroblasts
by: Bethany Claridge, et al.
Published: (2023-12-01) -
Editorial: Cardiac Fibrosis, From Lineage Tracing to Therapeutic Application
by: Claudio de Lucia, et al.
Published: (2021-01-01) -
Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities
by: Ruiqiang Qi, et al.
Published: (2022-12-01) -
Impaired cardiomyocytes accelerate cardiac hypertrophy and fibrosis by delivering exosomes containing Shh/N-Shh/Gli1 in angiotensin II infused mice
by: Cong Wang, et al.
Published: (2024-10-01) -
Cardiac Fibrosis and Cardiac Fibroblast Lineage-Tracing: Recent Advances
by: Xing Fu, et al.
Published: (2020-05-01)